Patents Assigned to Viamet Pharmaceuticals (Bermuda), Ltd.
  • Metalloenzyme inhibitor compounds
    Patent number: 10085984
    Abstract: Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: October 2, 2018
    Assignee: Viamet Pharmaceuticals (Bermuda), Ltd.
    Inventors: Steven Sparks, Christopher M. Yates, Sammy R. Shaver, William J. Hoekstra